2009Xinxueguan kangfu yixue zazhiRequires access

Effects of simvastatin combined with clopidogrel on hs-CRP and blood lipids in patients with acute coronary syndrome

Shao-Wei Chen

Open publisher page 0 citations

Abstract

Objective:To investigate the effects of simvastatin combined with clopidogrel on high sensitivity C-reactive protein(hs-CRP) and blood lipids in patients with acute coronary syndrome(ACS).Methods:A total of 117 patients with ACS were divided into two groups: simvastatin group(48 patients) and simvastatin combined with clopidogrel group(69 patients).The levels of hs-CRP and blood lipids were detected before and six-week after treatment.Results:The hs-CRP and blood lipids levels of patients significantly decreased in two groups(P0.01 all).Compared with simvastatin group,the hs-CRP levels significantly decreased(P0.05),but the blood lipids levels had not significant decreased(P0.05)in simvastatin combined with clopidogrel group.Conclusion:Treatment with simvastatin combination with clopidogrel not only decrease the blood lipids levels but also has the best effects on lowering hs-CRP.It suggest that it may inhibit inflammatory responses,increase atherosclerotic plaque stabilization in ACS patients.

About this research paper

What this paper is about

Objective:To investigate the effects of simvastatin combined with clopidogrel on high sensitivity C-reactive protein(hs-CRP) and blood lipids in patients with acute coronary syndrome(ACS).Methods:A total of 117 patients with ACS were divided into two groups: simvastatin group(48 patients) and simvastatin combined with clopidogrel group(69 patients).The levels of hs-CRP and blood lipids were detected before and six-week after treatment.Results:The hs-CRP and blood lipids levels of patients significantly decreased in two groups(P0.01 all).Compared with simvastatin group,the hs-CRP levels significantly decreased(P0.05),but the blood lipids levels had not significant decreased(P0.05)in simvastatin combined with clopidogrel group.Conclusion:Treatment with simvastatin combination with clopidogrel not only decrease the blood lipids levels but also has the best effects on lowering hs-CRP.It suggest that it may inhibit inflammatory responses,increase atherosclerotic plaque stabilization in ACS patients.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To investigate the effects of simvastatin combined with clopidogrel on high sensitivity C-reactive protein(hs-CRP) and blood lipids in patients with acute coronary syndrome(ACS).Methods:A total of 117 patients with ACS were divided into two groups: simvastatin group(48 patients) and simvastatin combined with clopidogrel group(69 patients).The levels of hs-CRP and blood lipids were detected before and six-week after treatment.Results:The hs-CRP and blood lipids levels of patients significantly decreased in two groups(P0.01 all).Compared with simvastatin group,the hs-CRP levels significantly decreased(P0.05),but the blood lipids levels had not significant decreased(P0.05)in simvastatin combined with clopidogrel group.Conclusion:Treatment with simvastatin combination with clopidogrel not only decrease the blood lipids levels but also has the best effects on lowering hs-CRP.It suggest that it may inhibit inflammatory responses,increase atherosclerotic plaque stabilization in ACS patients.

Key concepts: Simvastatin, Medicine, Clopidogrel, Acute coronary syndrome, Blood lipids, Internal medicine, C-reactive protein, Aspirin

Related papers

Back to paper searchBrowse research topicsOriginal source
Effects of simvastatin combined with clopidogrel on hs-CRP and blood lipids in patients with acute coronary syndrome — Research Paper | ScholarLens